Literature DB >> 22213704

Isolation of synaptic terminals from Alzheimer's disease cortex.

Sophie Sokolow1, Kristen M Henkins, Iris A Williams, Harry V Vinters, Ingrid Schmid, Gregory M Cole, Karen H Gylys.   

Abstract

Amyloid beta (Aβ) oligomers and phosphorylated tau (p-tau) aggregates are increasingly identified as potential toxic intermediates in Alzheimer's disease (AD). In cortical AD synapses, p-tau co-localizes with Aβ, but the Aβ and p-tau peptide species responsible for synaptic dysfunction and demise remains unclear. The present experiments were designed to use high-speed cell sorting techniques to purify synaptosome population based on size, and then extend the method to physically isolate Aβ-positive synaptosomes with the goal of understanding the nature of Aβ and tau pathology in AD synapses. To examine the purity of size-gated synaptosomes, samples were first gated on size; particles with sizes between 0.5 and 1.5 microns were collected. Electron microscopy documented a homogenous population of spherical particles with internal vesicles and synaptic densities. Next, size-gated synaptosomes positive for Aβ were collected by fluorescence activated sorting and then analyzed by immunoblotting techniques. Sorted Aβ-positive synaptosomes were enriched for amyloid precursor protein (APP) and for Aβ oligomers and aggregates; immunolabeling for p-tau showed a striking accumulation of p-tau aggregates compared to the original homogenate and purified synaptosomes. These results confirm co-localization of Aβ and p-tau within individual synaptic terminals and provide proof of concept for the utility of flow sorting synaptosomes.
Copyright © 2011 International Society for Advancement of Cytometry.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22213704      PMCID: PMC3315390          DOI: 10.1002/cyto.a.22009

Source DB:  PubMed          Journal:  Cytometry A        ISSN: 1552-4922            Impact factor:   4.355


  25 in total

1.  Flow cytometric analysis of rat striatal nerve terminals.

Authors:  M E Wolf; G Kapatos
Journal:  J Neurosci       Date:  1989-01       Impact factor: 6.167

2.  Quantitative characterization of crude synaptosomal fraction (P-2) components by flow cytometry.

Authors:  K H Gylys; J A Fein; G M Cole
Journal:  J Neurosci Res       Date:  2000-07-15       Impact factor: 4.164

3.  The naming of voltage-gated calcium channels.

Authors:  L Birnbaumer; K P Campbell; W A Catterall; M M Harpold; F Hofmann; W A Horne; Y Mori; A Schwartz; T P Snutch; T Tanabe
Journal:  Neuron       Date:  1994-09       Impact factor: 17.173

4.  Synaptic changes in Alzheimer's disease: increased amyloid-beta and gliosis in surviving terminals is accompanied by decreased PSD-95 fluorescence.

Authors:  Karen Hoppens Gylys; Jeffrey A Fein; Fusheng Yang; Dorothy J Wiley; Carol A Miller; Gregory M Cole
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

Review 5.  Structural correlates of cognition in dementia: quantification and assessment of synapse change.

Authors:  S T DeKosky; S W Scheff; S D Styren
Journal:  Neurodegeneration       Date:  1996-12

6.  Apolipoprotein E enhances uptake of soluble but not aggregated amyloid-beta protein into synaptic terminals.

Authors:  Karen H Gylys; Jeffrey A Fein; Aiko M Tan; Gregory M Cole
Journal:  J Neurochem       Date:  2003-03       Impact factor: 5.372

7.  Polyclonals to beta-amyloid(1-42) identify most plaque and vascular deposits in Alzheimer cortex, but not striatum.

Authors:  K Mak; F Yang; H V Vinters; S A Frautschy; G M Cole
Journal:  Brain Res       Date:  1994-12-19       Impact factor: 3.252

8.  Enrichment of presynaptic and postsynaptic markers by size-based gating analysis of synaptosome preparations from rat and human cortex.

Authors:  Karen H Gylys; Jeffrey A Fein; Fusheng Yang; Gregory M Cole
Journal:  Cytometry A       Date:  2004-07       Impact factor: 4.355

9.  Alzheimer disease in the US population: prevalence estimates using the 2000 census.

Authors:  Liesi E Hebert; Paul A Scherr; Julia L Bienias; David A Bennett; Denis A Evans
Journal:  Arch Neurol       Date:  2003-08

10.  Biochemical characterization of a filtered synaptoneurosome preparation from guinea pig cerebral cortex: cyclic adenosine 3':5'-monophosphate-generating systems, receptors, and enzymes.

Authors:  E B Hollingsworth; E T McNeal; J L Burton; R J Williams; J W Daly; C R Creveling
Journal:  J Neurosci       Date:  1985-08       Impact factor: 6.167

View more
  17 in total

1.  Pre-synaptic C-terminal truncated tau is released from cortical synapses in Alzheimer's disease.

Authors:  Sophie Sokolow; Kristen M Henkins; Tina Bilousova; Bianca Gonzalez; Harry V Vinters; Carol A Miller; Lindsey Cornwell; Wayne W Poon; Karen H Gylys
Journal:  J Neurochem       Date:  2015-01-13       Impact factor: 5.372

2.  Cytometry in the brain: studying differentiation to diagnostic applications in brain disease and regeneration therapy.

Authors:  H Ulrich; J Bocsi; T Glaser; A Tárnok
Journal:  Cell Prolif       Date:  2014-02       Impact factor: 6.831

3.  Mass synaptometry: High-dimensional multi parametric assay for single synapses.

Authors:  Chandresh R Gajera; Rosemary Fernandez; Nadia Postupna; Kathleen S Montine; Edward J Fox; Dmitry Tebaykin; Michael Angelo; Sean C Bendall; C Dirk Keene; Thomas J Montine
Journal:  J Neurosci Methods       Date:  2018-11-20       Impact factor: 2.390

4.  Apolipoprotein E/Amyloid-β Complex Accumulates in Alzheimer Disease Cortical Synapses via Apolipoprotein E Receptors and Is Enhanced by APOE4.

Authors:  Tina Bilousova; Mikhail Melnik; Emily Miyoshi; Bianca L Gonzalez; Wayne W Poon; Harry V Vinters; Carol A Miller; Maria M Corrada; Claudia Kawas; Asa Hatami; Ricardo Albay; Charles Glabe; Karen H Gylys
Journal:  Am J Pathol       Date:  2019-05-17       Impact factor: 4.307

5.  Human Striatal Dopaminergic and Regional Serotonergic Synaptic Degeneration with Lewy Body Disease and Inheritance of APOE ε4.

Authors:  Nadia Postupna; Caitlin S Latimer; Eric B Larson; Emily Sherfield; Julie Paladin; Carol A Shively; Matthew J Jorgensen; Rachel N Andrews; Jay R Kaplan; Paul K Crane; Kathleen S Montine; Suzanne Craft; C Dirk Keene; Thomas J Montine
Journal:  Am J Pathol       Date:  2017-02-16       Impact factor: 4.307

6.  Survivin, a target to modulate the radiosensitivity of Ewing's sarcoma.

Authors:  B Greve; F Sheikh-Mounessi; B Kemper; I Ernst; M Götte; H T Eich
Journal:  Strahlenther Onkol       Date:  2012-10-10       Impact factor: 3.621

Review 7.  The role of synaptic microRNAs in Alzheimer's disease.

Authors:  Subodh Kumar; P Hemachandra Reddy
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2020-08-20       Impact factor: 5.187

8.  Synaptic Amyloid-β Oligomers Precede p-Tau and Differentiate High Pathology Control Cases.

Authors:  Tina Bilousova; Carol A Miller; Wayne W Poon; Harry V Vinters; Maria Corrada; Claudia Kawas; Eric Y Hayden; David B Teplow; Charles Glabe; Ricardo Albay; Gregory M Cole; Edmond Teng; Karen H Gylys
Journal:  Am J Pathol       Date:  2016-01       Impact factor: 4.307

9.  Murine BST2/tetherin promotes measles virus infection of neurons.

Authors:  Katelyn D Miller; Christine Matullo; Riley Williams; Carli B Jones; Glenn F Rall
Journal:  Virology       Date:  2021-08-15       Impact factor: 3.616

10.  cAMP-PKA phosphorylation of tau confers risk for degeneration in aging association cortex.

Authors:  Becky C Carlyle; Angus C Nairn; Min Wang; Yang Yang; Lu E Jin; Arthur A Simen; Brian P Ramos; Kelly A Bordner; George E Craft; Peter Davies; Mihovil Pletikos; Nenad Šestan; Amy F T Arnsten; Constantinos D Paspalas
Journal:  Proc Natl Acad Sci U S A       Date:  2014-03-18       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.